JMJ703 Antibody

What is JMJ703 and what is its primary function in plants?

JMJ703 is a Jumonji C (JmjC) domain-containing protein that functions as a histone lysine demethylase, specifically removing methyl groups from all three methylation states of histone H3 lysine 4 (H3K4me1/2/3) . As demonstrated through crystallography and enzymatic assays, JMJ703 utilizes Fe(II) and α-ketoglutarate as cofactors to catalyze the demethylation reaction .

In plants, particularly rice, JMJ703 serves as a critical epigenetic regulator with multiple functions:

• Transcriptional repression through removal of activating H3K4 methylation marks

• Silencing of transposable elements, specifically non-LTR retrotransposons like Karma and LINE1

• Maintenance of genome stability by preventing excessive transposon activity

• Regulation of developmental processes, as evidenced by pleiotropic phenotypes in jmj703 mutants

Loss-of-function mutations in JMJ703 lead to increased H3K4me3 levels, enhanced genome-wide transcription (affecting over 3,900 genes), and various developmental abnormalities . This demonstrates the critical importance of JMJ703-mediated histone demethylation in proper plant growth and development.

How does the structure of JMJ703 contribute to its specificity for H3K4 demethylation?

The molecular basis for JMJ703's specificity toward H3K4 methylation involves several structural features:

• Core catalytic domain: While the JmjC domain and catalytic center share topological similarities with other JmjC proteins (root mean square derivations of 1.75 Å and 1.81 Å relative to c-JMJD2A and c-Rph1), JMJ703 exhibits distinctive structural elements .

• JmjN domain orientation: Unlike other JmjC proteins, the N-terminus of JMJ703 is oriented in the opposite direction compared to JMJD2A and Rph1, contributing to its unique substrate recognition capabilities .

• β-hairpin structure: JMJ703 contains a modified β-hairpin domain with two shorter β-strands (β2 and β3) and an additional α-helix (α4), creating a distinctive substrate binding pocket .

• Methyl-lysine binding pocket: Five key residues (G376, Y383, E396, A494, and N496) form a specialized pocket that recognizes and binds the methylated lysine. Mutation studies confirm their essential role, as substitutions like G376A, Y383A, and E396A significantly impair H3K4 demethylase activity .

• H3K4-specific recognition residues: Sequence alignment reveals several residues conserved specifically among H3K4 demethylases that contribute to substrate specificity .

These structural features collectively enable JMJ703 to distinguish between different histone methylation sites and specifically target H3K4 methylation for demethylation.

What is the relationship between JMJ703 activity and DNA methylation in transposon silencing?

JMJ703 plays a crucial role in coordinating histone demethylation with DNA methylation to maintain transposon silencing:

• Inverse correlation pattern: JMJ703 activity creates an inverse relationship between H3K4me3 and DNA methylation. At targets like the Karma transposon, wild-type plants show low H3K4me3 and high DNA methylation, while jmj703 mutants display increased H3K4me3 and reduced DNA methylation .

• CpG methylation impact: Bisulfite sequencing revealed that CpG methylation at the Karma 5' region decreased dramatically from 75.89% in wild-type to 30.55% in jmj703 mutants. Non-CG methylation was less affected (CHG from 5.27% to 1.55%; CHH from 3.34% to 1.57%) .

• Mechanistic model:

  • JMJ703 removes active H3K4me3 marks from transposon chromatin

  • This enables DNA methyltransferase recruitment and activity

  • The resulting repressive chromatin environment prevents transposon activation

• Transposon specificity: JMJ703 specifically targets certain non-LTR retrotransposons (Karma and LINE1) but not others (like the LTR retrotransposon Tos17) . This selective regulation suggests precise targeting mechanisms.

This relationship represents a unique epigenetic regulatory mechanism that links histone demethylation directly to DNA methylation and transposon silencing, reinforcing the critical role of JMJ703 in genome stability.

What are the optimal conditions for using JMJ703 antibodies in ChIP-seq experiments?

Optimizing ChIP-seq experiments with JMJ703 antibodies requires attention to several critical parameters:

• Antibody selection and validation:

  • Choose antibodies specifically validated for ChIP applications

  • Confirm specificity using Western blotting against wild-type and jmj703 mutant samples

  • Consider epitope location and accessibility within the protein structure

• Chromatin preparation protocol:

  • Use 1% formaldehyde for 10-15 minutes at room temperature for crosslinking

  • Optimize sonication to achieve 200-500 bp fragments

  • Assess sonication efficiency by agarose gel electrophoresis

  • For plant tissues, include nuclei isolation steps to reduce background

• Immunoprecipitation conditions:

  • Antibody amount: 2-5 μg per IP reaction

  • Chromatin amount: 10-25 μg per IP reaction

  • Incubation: Overnight at 4°C with gentle rotation

  • Include appropriate blocking agents to minimize non-specific binding

• Washing stringency:

  • Use progressively higher salt concentrations (150-500 mM NaCl)

  • Include detergent (0.1% SDS, 1% Triton X-100) in wash buffers

  • Perform 4-6 washes to reduce background

• Controls and normalization:

  • Input DNA control (pre-immunoprecipitation)

  • IgG control for non-specific binding

  • Anti-H3 ChIP as a loading control

  • Spike-in with foreign chromatin for quantitative comparisons

• Sequencing parameters:

  • Minimum 20-30 million uniquely mapped reads per sample

  • Paired-end sequencing for better mapping of repetitive regions

  • Include at least 2-3 biological replicates

For data analysis, published studies with JMJ703 have successfully identified differentially bound regions by comparing H3K4me3 peaks between wild-type and jmj703 mutants, using a threshold of at least 1.5-fold change in enrichment .

How can I validate the specificity of a JMJ703 antibody for epigenetic studies?

Rigorous validation of JMJ703 antibodies is essential for reliable experimental outcomes. A comprehensive validation strategy should include:

• Genetic validation approaches:

  • Western blot comparison between wild-type and jmj703 knockout/knockdown samples

  • The specific band should be absent or significantly reduced in mutant samples

  • This represents the gold standard for antibody validation

• Peptide competition assays:

  • Pre-incubate the antibody with excess immunizing peptide

  • Compare signal with and without peptide competition

  • Specific signal should be blocked while non-specific binding may persist

• Multiple antibody comparison:

  • Test antibodies targeting different epitopes of JMJ703

  • Consistent results across different antibodies increase confidence

  • Consider both monoclonal and polyclonal antibodies for complementary approaches

• Recombinant protein testing:

  • Express JMJ703 fragments as recombinant proteins

  • Test antibody reactivity against these defined proteins

  • Include related JmjC proteins to assess cross-reactivity

• Application-specific validation:

  • For ChIP: Compare enrichment at known JMJ703 targets versus non-targets

  • For Western blotting: Confirm the expected molecular weight (~17 kDa for histone H3)

  • For immunofluorescence: Verify nuclear localization pattern

• Orthogonal approaches:

  • Correlate antibody-based detection with mRNA expression

  • Use epitope-tagged JMJ703 constructs and compare detection with tag-specific antibodies

  • An example approach is using FLAG-HA tagged JMJ703 constructs as seen in published studies

Proper validation ensures that experimental results reflect true JMJ703 biology rather than antibody artifacts.

What methods can distinguish direct from indirect targets of JMJ703?

Distinguishing direct from indirect targets of JMJ703 demethylase activity requires integrative approaches that establish causality:

• Integrated genomic analysis:

  • Direct targets should exhibit: (1) JMJ703 binding in ChIP, (2) increased H3K4me3 in jmj703 mutants, and (3) altered expression

  • This multi-parameter approach was used to identify Karma and LINE1 as direct JMJ703 targets

• Temporal induction studies:

  • Use inducible JMJ703 depletion or complementation systems

  • Early-responding genes (within hours) are more likely to be direct targets

  • Later responses (days) often represent secondary effects

• Catalytic activity dependence:

  • Compare effects of wild-type JMJ703 versus catalytically inactive mutants (e.g., JMJ703H394A)

  • Direct targets dependent on demethylation should respond differently to catalytic mutants

  • This approach separates enzymatic from potential scaffolding functions

• Targeted epigenetic editing:

  • Use dCas9-JMJ703 fusions to target specific loci

  • Direct targets should respond to targeted recruitment

  • Controls should include catalytically inactive versions

• In vitro biochemical validation:

  • Perform in vitro demethylation assays with reconstituted chromatin containing target sequences

  • Direct targets should be demethylated by purified JMJ703 protein

  • Similar to the in vitro assays performed with bulk histones

• High-resolution mapping techniques:

  • Use ChIP-exo or CUT&RUN for precise binding site identification

  • Direct targets should show JMJ703 binding precisely at or near affected H3K4me3 sites

The most convincing evidence comes from combining multiple approaches. For example, researchers identified the retrotransposons Karma and LINE1 as direct JMJ703 targets through integrated analysis of ChIP-qPCR, H3K4me3 levels, expression changes, DNA methylation status, and genetic complementation studies .

How does JMJ703 activity influence genome-wide transcription patterns?

JMJ703 demethylase activity has profound effects on genome-wide transcription patterns, as revealed through comprehensive transcriptomic analysis:

• Global expression changes:

  • RNA-seq analysis of jmj703 mutants identified 2,424 up-regulated and 1,536 down-regulated genes compared to wild-type

  • This indicates that JMJ703 functions as both a repressor and indirect activator of gene expression

• Correlation with H3K4me3 changes:

  • Of genes with increased H3K4me3 in jmj703 mutants, 23.8% showed upregulated expression (p = 0.0003)

  • Only 2 down-regulated genes showed increased H3K4me3 (p = 0.27)

  • This confirms that elevated H3K4me3 is preferentially associated with transcriptional activation

• Functional categories affected:

  • Genes involved in chromatin assembly are particularly deregulated in jmj703 mutants

  • This suggests JMJ703 plays a role in maintaining proper chromatin organization

• Transposon activation:

  • LINE elements like Karma and LINE1 show increased expression in jmj703 mutants

  • This correlates with increased H3K4me3 and decreased DNA methylation

  • Notably, not all transposons are affected (e.g., Tos17), indicating specificity

• Secondary regulatory effects:

  • Many expression changes likely represent indirect effects through regulatory cascades

  • JMJ703 may regulate transcription factors or other epigenetic modifiers

This complex pattern of gene expression changes contributes to the pleiotropic developmental phenotypes observed in jmj703 mutants, highlighting the critical role of JMJ703-mediated H3K4 demethylation in transcriptional regulation.

What are the critical amino acid residues in JMJ703 for substrate recognition and catalysis?

Structural and functional studies have identified several key amino acid residues in JMJ703 that are essential for its demethylase activity:

• Catalytic core residues:

  • The JmjC domain contains a Fe(II)-binding site crucial for catalytic activity

  • H394 is a critical catalytic residue, as JMJ703H394A mutants lack demethylase activity

• Methyl group binding pocket:

  • Five key residues form a pocket that recognizes methylated lysine:

    • G376: Mutation to alanine (G376A) impairs demethylase activity

    • Y383: Y383A mutation retains partial activity against H3K4me2

    • E396: E396A mutation impairs demethylase activity

    • A494: Corresponds to S288 in JMJD2A

    • N496: N496A mutation retains activity against H3K4me2/3

• α-KG binding residues:

  • Y321: Unlike in other JmjC proteins, Y321 in JMJ703 may not directly contact α-KG

  • N404: A JMJ703-specific feature involved in cofactor binding

• H3K4 demethylase-specific residues:

  • Several conserved residues are specifically found in H3K4 demethylases

  • These residues are positioned within the JmjC domain to create H3K4 specificity

  • They form part of the substrate binding pocket that accommodates the H3K4me3 peptide

These structure-function relationships provide critical insights into the molecular mechanism of JMJ703-mediated histone demethylation and the basis for its substrate specificity.

What experimental approaches can detect the dynamic recruitment of JMJ703 during development or stress responses?

Studying the dynamic recruitment of JMJ703 during developmental processes or stress responses requires specialized techniques that capture temporal and spatial dynamics:

• Time-course ChIP-seq analysis:

  • Perform ChIP-seq at multiple time points during development or stress treatment

  • Identify sites with differential JMJ703 occupancy over time

  • Correlate with changes in H3K4me3, DNA methylation, and gene expression

• Live-cell imaging approaches:

  • Generate fluorescent protein fusions with JMJ703 (e.g., JMJ703-GFP)

  • Validate functionality by complementation of jmj703 mutants

  • Use confocal microscopy to track localization during developmental transitions

  • Consider photoactivatable or photoswitchable fluorescent proteins for pulse-chase experiments

• Tissue-specific profiling:

  • Use fluorescence-activated cell sorting (FACS) to isolate specific cell types

  • Perform cell type-specific ChIP-seq using tissue-specific promoters

  • Apply single-cell approaches for heterogeneous tissues

• Inducible systems:

  • Create inducible JMJ703 expression systems using promoters like dexamethasone-inducible or heat-shock inducible

  • Track immediate changes in H3K4me3 and gene expression upon induction

  • Useful for separating primary from secondary effects

• Proximity-dependent labeling:

  • Fuse JMJ703 with BioID or TurboID for proximity-dependent biotinylation

  • Identify proteins that interact with JMJ703 during specific conditions

  • Map temporal changes in the JMJ703 interactome

• Advanced ChIP approaches:

  • Use CUT&RUN or CUT&Tag for higher resolution and lower background

  • Apply spike-in normalization for quantitative comparisons between conditions

  • Consider ChIP-SICAP to identify chromatin-bound protein complexes

• Chromosome conformation capture:

  • Combine with ChIP (ChIA-PET or HiChIP) to map JMJ703-mediated chromatin interactions

  • Identify long-range interactions that change during development

Similar approaches have been successfully applied to study the dynamic recruitment of other chromatin modifiers, and could be adapted for JMJ703 research, particularly in understanding its role in transposon silencing and developmental regulation.

What factors might contribute to inconsistent ChIP-seq results with JMJ703 antibodies?

Inconsistent ChIP-seq results with JMJ703 antibodies can arise from multiple technical and biological factors:

• Antibody-related factors:

  • Lot-to-lot variability in commercial antibodies

  • Degradation of antibodies due to improper storage

  • Insufficient validation for the specific application

  • Cross-reactivity with related JmjC domain proteins

• Chromatin preparation issues:

  • Inconsistent crosslinking efficiency

  • Variable sonication leading to different fragment sizes

  • Inadequate nuclei isolation from plant tissues

  • Over-fixation masking epitopes

• Experimental variability:

  • Inconsistent washing stringency between experiments

  • Temperature fluctuations during immunoprecipitation

  • Variable protein-protein crosslinking efficiency

  • Inconsistent reverse crosslinking conditions

• Biological variables:

  • Developmental stage differences between samples

  • Stress conditions affecting JMJ703 recruitment

  • Circadian or diurnal effects on JMJ703 activity

  • Tissue heterogeneity in samples

• Sequencing and bioinformatic challenges:

  • Inconsistent sequencing depth

  • Different mapping strategies for repetitive regions

  • Variation in peak calling parameters

  • Batch effects between sequencing runs

• Plant-specific considerations:

  • Secondary metabolites interfering with antibody binding

  • Cell wall components affecting chromatin extraction

  • Different fixation requirements for plant tissues

Troubleshooting strategies should include rigorous standardization of protocols, inclusion of spike-in controls, simultaneous processing of samples, and validation of key findings using orthogonal methods like ChIP-qPCR. Researchers should particularly focus on optimizing chromatin preparation from plant tissues, as protocols optimized for mammalian cells may require significant adaptation for plant materials.

How can I optimize western blot protocols for detecting JMJ703 protein?

Optimizing western blot protocols for JMJ703 detection requires attention to several critical parameters:

• Sample preparation:

  • Use fresh tissue whenever possible

  • Include protease inhibitors in extraction buffers

  • Consider nuclear extraction to enrich for JMJ703

  • Use denaturing conditions (SDS, heat) to ensure complete protein denaturation

• Gel electrophoresis parameters:

  • Use 8-10% acrylamide gels for optimal resolution of JMJ703

  • Load 30-50 μg of total protein per lane

  • Include positive controls (recombinant JMJ703) and negative controls (jmj703 mutant)

  • Use pre-stained markers that cover the expected molecular weight range

• Transfer conditions:

  • For large proteins like JMJ703, use wet transfer with low SDS (0.01%)

  • Transfer at lower voltage (30V) overnight at 4°C for complete transfer

  • Use PVDF membranes for better protein retention

  • Verify transfer efficiency with reversible staining (Ponceau S)

• Blocking optimization:

  • Test different blocking agents (5% milk, 3-5% BSA, commercial blockers)

  • Block for 1-2 hours at room temperature or overnight at 4°C

  • For phospho-specific antibodies, use BSA instead of milk

• Antibody parameters:

  • Optimize primary antibody dilution (start with 1:1000 and adjust as needed)

  • Incubate primary antibody overnight at 4°C with gentle agitation

  • Optimize secondary antibody dilution (typically 1:5000-1:10000)

  • Consider using secondary antibodies with enhanced sensitivity

• Washing and detection:

  • Use TBST with 0.1% Tween-20 for washing

  • Perform 3-5 washes of 5-10 minutes each

  • For low abundance proteins, use enhanced chemiluminescence (ECL) substrates

  • Consider using fluorescent secondary antibodies for quantitative analysis

• Controls and validation:

  • Include anti-H3 antibody as a loading control

  • Use wild-type and jmj703 mutant samples to confirm specificity

  • For tagged constructs, compare detection with both JMJ703 and tag antibodies

Based on similar histone-related antibodies, a starting dilution of 1:1000 for western blotting is recommended , but this should be optimized for each specific JMJ703 antibody.

What strategies can overcome epitope masking issues in JMJ703 immunoprecipitation experiments?

Epitope masking can significantly reduce the efficiency of JMJ703 immunoprecipitation. Several strategies can help overcome this challenge:

• Antigen retrieval methods:

  • Heat-mediated antigen retrieval (95-100°C for 10-20 minutes in retrieval buffer)

  • Enzymatic antigen retrieval (limited protease digestion)

  • pH-based methods (try buffers with different pH values from 6.0-9.0)

  • These approaches can help expose hidden epitopes after fixation

• Crosslinking optimization:

  • Test different formaldehyde concentrations (0.1-1%)

  • Vary crosslinking times (5-20 minutes)

  • Consider alternative crosslinkers like DSG or EGS for protein-protein interactions

  • Use dual crosslinking strategies (e.g., DSG followed by formaldehyde)

• Extraction and solubilization:

  • Test different detergent combinations (Triton X-100, NP-40, SDS, Sarkosyl)

  • Try sonication versus enzymatic digestion (MNase) for chromatin fragmentation

  • Use higher salt concentrations (up to 500 mM NaCl) in extraction buffers

  • Include denaturants at low concentrations to partially unfold proteins

• Antibody selection and approach:

  • Use antibodies targeting different epitopes of JMJ703

  • Consider polyclonal antibodies that recognize multiple epitopes

  • For tagged JMJ703, use tag-specific antibodies as an alternative approach

  • Try native ChIP (without crosslinking) for abundant targets

• Sequential ChIP approach:

  • Perform ChIP with antibodies against known JMJ703 partners first

  • Re-ChIP the eluted material with JMJ703 antibodies

  • This can help isolate JMJ703 in its functional complexes

• Fragment size optimization:

  • Generate larger fragments for complex integrity (400-600 bp)

  • Use smaller fragments for higher resolution (100-300 bp)

  • Test a range of sonication conditions to determine optimal protocol

• Alternative approaches:

  • CUT&RUN or CUT&Tag, which use native unfixed cells

  • Biotin-tagging of JMJ703 for streptavidin pulldown

  • DamID for detecting chromatin associations without antibodies

These strategies should be tested systematically, comparing results with known JMJ703 targets like Karma and LINE1 to determine which approach yields the most specific and sensitive detection of JMJ703 binding sites.

How should researchers integrate JMJ703 ChIP-seq data with other epigenomic datasets?

Integrating JMJ703 ChIP-seq data with other epigenomic datasets provides a comprehensive understanding of its function within the broader epigenetic landscape:

• Multi-layer data integration approach:

  • Combine JMJ703 binding data with H3K4me1/2/3 profiles

  • Integrate DNA methylation data, especially at transposable elements

  • Incorporate transcriptome data (RNA-seq) to connect binding with gene expression

  • Include chromatin accessibility data (ATAC-seq or DNase-seq)

• Correlation analysis methods:

  • Calculate Pearson or Spearman correlation between different epigenetic marks

  • Perform principal component analysis to identify major sources of variation

  • Use k-means clustering to identify regions with similar epigenetic signatures

  • Apply machine learning approaches to predict JMJ703 binding sites

• Genomic feature analysis:

  • Examine distribution across genomic elements (promoters, gene bodies, enhancers)

  • Compare enrichment at repetitive elements versus unique sequences

  • Analyze distance to transcription start sites and correlation with expression

  • Study co-localization with other chromatin regulators

• Visualization strategies:

  • Generate metaplots centered on JMJ703 binding sites

  • Create heatmaps showing multiple marks across different genomic regions

  • Use genome browsers for detailed inspection of individual loci

  • Develop Circos plots for genome-wide integration view

• Functional enrichment analysis:

  • Perform Gene Ontology analysis of JMJ703-bound genes

  • Conduct pathway enrichment analysis

  • Analyze transcription factor binding motifs at JMJ703 sites

  • Examine evolutionary conservation of binding patterns

• Temporal and condition-specific integration:

  • Compare epigenetic landscapes across different developmental stages

  • Analyze stress-responsive epigenetic changes

  • Track dynamics of multiple marks during biological transitions

Published studies successfully utilized integration approaches to identify direct JMJ703 targets. For example, researchers integrated H3K4me3 ChIP-seq and RNA-seq data from wild-type and jmj703 mutants to identify genes with both increased H3K4me3 and altered expression. This approach led to the discovery of transposons like Karma and LINE1 as direct JMJ703 targets .

What statistical approaches are most appropriate for identifying differential JMJ703 binding sites?

Identifying differential JMJ703 binding sites requires robust statistical frameworks that account for biological and technical variability:

• Count-based differential binding analysis:

  • DESeq2: Utilizes negative binomial distribution to model count data

  • edgeR: Similar to DESeq2 but with different normalization strategies

  • DiffBind: Specialized package for differential binding analysis

  • These methods require biological replicates (minimum 2-3 per condition)

• Appropriate normalization methods:

  • TMM (Trimmed Mean of M-values): Accounts for composition biases

  • Spike-in normalization: Uses exogenous DNA to control for technical variation

  • Input normalization: Corrects for background enrichment

  • Quantile normalization: Equalizes distributions between samples

• Multiple testing correction:

  • Benjamini-Hochberg procedure: Controls false discovery rate

  • Bonferroni correction: More stringent control of family-wise error rate

  • q-value methods: Estimate proportion of false positives

• Effect size considerations:

  • Log2 fold change thresholds (e.g., ≥1.5-fold change used in JMJ703 studies)

  • Signal intensity filters to exclude low-coverage regions

  • Consistency requirements across replicates

• Peak calling strategies:

  • Sample-specific peak calling followed by differential analysis

  • Multi-sample peak calling to create consensus peaksets

  • Signal extraction from consistent genomic windows

• Specialized approaches for histone modifications:

  • Broad vs. narrow peak analysis

  • Domain-level analysis for large modified regions

  • Shape-based analysis for pattern changes

• Visualization and assessment:

  • MA plots to visualize fold changes versus mean counts

  • Volcano plots to display statistical significance versus effect size

  • PCA plots to assess replicate consistency and condition separation

For JMJ703 studies, researchers have successfully identified differential binding by comparing H3K4me3 enrichment between wild-type and jmj703 mutants, using a combination of fold-change thresholds (≥1.5-fold) and statistical significance metrics . This approach can be adapted for direct JMJ703 ChIP-seq analysis with appropriate controls and replicates.

How can researchers distinguish between JMJ703's roles in developmental regulation versus transposon silencing?

Distinguishing between JMJ703's developmental and transposon silencing functions requires sophisticated analytical approaches that separate these interconnected roles:

• Genomic context analysis:

  • Compare JMJ703 binding patterns at developmental genes versus transposons

  • Analyze differences in H3K4me3 profiles and DNA methylation patterns

  • Examine the response to JMJ703 depletion in different genomic contexts

• Temporal and tissue-specific approaches:

  • Conduct stage-specific and tissue-specific epigenomic profiling

  • Identify differential recruitment of JMJ703 during development

  • Compare transposon regulation across different developmental stages

  • Developmental genes may show stage-specific regulation while transposon silencing might be more constitutive

• Mutant phenotype analysis:

  • Create domain-specific mutations affecting different JMJ703 functions

  • Separate mutations affecting catalytic activity from those affecting targeting

  • Generate targeted epigenetic editing of specific loci to test direct effects

  • Perform genetic complementation with domain deletion variants

• Interactome characterization:

  • Identify tissue-specific JMJ703 interaction partners

  • Compare protein complexes at developmental genes versus transposons

  • Use proximity labeling approaches (BioID/TurboID) in different contexts

• Evolutionary analysis:

  • Compare conservation of JMJ703 binding sites across related species

  • Developmental functions often show higher conservation

  • Transposon targets may show more rapid evolutionary dynamics

• Mechanistic separation:

  • Analyze recruitment mechanisms (sequence-specific versus epigenetic features)

  • Identify distinct histone modification patterns at different target classes

  • Examine co-factors required for different functions

• Functional output analysis:

  • Developmental targets often affect specific pathways

  • Transposon regulation primarily affects genome stability

  • Perform gene set enrichment analysis to identify affected biological processes

Research has shown that JMJ703 targets specific non-LTR retrotransposons like Karma and LINE1, but not all transposons (e.g., Tos17 is unaffected) . This selectivity suggests precise targeting mechanisms that differ from its developmental regulatory functions, providing a foundation for separating these distinct roles through the analytical approaches described above.